>
Big Tech's AI engines are becoming STUPID as they push narrative control
Robert F. Kennedy Jr. Announces Raids on Chinese Vape Products to Protect Children's Health
Close Friend Honors Iryna Zarutska with Heartfelt Tribute Video
AG Pam Bondi Clarifies Her Stance on First Amendment Following Backlash...
This "Printed" House Is Stronger Than You Think
Top Developers Increasingly Warn That AI Coding Produces Flaws And Risks
We finally integrated the tiny brains with computers and AI
Stylish Prefab Home Can Be 'Dropped' into Flooded Areas or Anywhere Housing is Needed
Energy Secretary Expects Fusion to Power the World in 8-15 Years
ORNL tackles control challenges of nuclear rocket engines
Tesla Megapack Keynote LIVE - TESLA is Making Transformers !!
Methylene chloride (CH2Cl?) and acetone (C?H?O) create a powerful paint remover...
Engineer Builds His Own X-Ray After Hospital Charges Him $69K
Researchers create 2D nanomaterials with up to nine metals for extreme conditions
For the first time, doctors have injected a person with a treatment that will rely on CRISPR gene-editing to treat blindness.
The milestone comes as part of an ongoing clinical trial to evaluate whether the treatment is safe and effective for people with a specific mutation in a single gene; in this case, one that leads to eye disease and vision loss.
CRISPR is a gene-editing tool adapted from the antiviral defense systems of bacteria that can precisely target and cut out short sequences of DNA from longer strands. The technique is being used in ongoing trials to treat cancer and sickle cell anemia by editing human cells outside the body and injecting them into a patient once they've been CRISPR'd; however, this blindness trial is the first that delivers the gene-editing treatment directly into a person's body, NPR reported—specifically, their eye.